companydata.dkAmicus Therapeutics ApS: Financial statements 2020
CVR: 39359340
Amicus Therapeutics ApS (CVR 39359340) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 490,223 and a net result of DKK 21,886 compared with DKK 84,291 the year before. That is a decrease of 75.7% compared with the year before. Equity amounted to DKK 229,709. The solvency ratio was 10%. The company had 1 employee in the financial year.
- Gross Profit
- 490,223 kr.
- Profit/Loss
- 21,886 kr.
- Equity
- 229,709 kr.
- Total Assets
- 2,286,341 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 490 t. | 22 t. | 230 t. | 1 |
| 2019 | - | 2 mio. | 84 t. | 208 t. | 2 |
| 2018 | - | 2 mio. | 74 t. | 124 t. | 2 |
How creditworthy is Amicus Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Amicus Therapeutics ApS has published its annual report for 2019. Gross profit came to DKK 2,019,085, and the net result was DKK 84,291.
As of February 28, 2020, John Erik Mattias Bankel has joined the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Anita Jane Clifford has joined the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Nicole Ruth Reichman has joined the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Johnny Krogh Hansen has left the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Simon Collins has left the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Lori Mochan has left the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, John Erik Mattias Bankel is registered as director of Amicus Therapeutics ApS.
As of February 28, 2020, Johnny Krogh Hansen has stepped down as director of Amicus Therapeutics ApS.
About Amicus Therapeutics ApS
Amicus Therapeutics ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Richard Gideon Morris. The company is owned by Amicus Therapeutics UK Ltd.. The company has 2 employees. In 2025, the company reported a gross profit of DKK 1,441,140 and a net result of DKK 115,004 compared with DKK 16,475 the year before. Equity amounted to DKK 424,641.